NASDAQ:CNTN Hillstream Biopharma Q4 2025 Earnings Report $2.30 0.00 (0.00%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$2.38 +0.08 (+3.26%) As of 06:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Hillstream Biopharma EPS ResultsActual EPS$0.54Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AHillstream Biopharma Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AHillstream Biopharma Announcement DetailsQuarterQ4 2025Date3/31/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Hillstream Biopharma Earnings HeadlinesHillstream Biopharma (NASDAQ:CNTN) Trading Down 0.5% - Should You Sell?September 15, 2026 | americanbankingnews.comCanton Strategic Holdings, Inc. Releases Second Quarter 2026 Financial and Operational ResultsAugust 14, 2026 | prnewswire.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.September 21 at 1:00 AM | InvestorPlace (Ad)Canton Strategic: Highly Intriguing Blockchain Treasury With Tangible RisksAugust 6, 2026 | seekingalpha.comThree New Directors Elected to the Board of Canton Strategic Holdings, Inc.July 28, 2026 | prnewswire.comCanton Strategic Holdings, Inc. Announces Sale of Gravitas Life Sciences, LLCJuly 23, 2026 | prnewswire.comSee More Hillstream Biopharma Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Hillstream Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hillstream Biopharma and other key companies, straight to your email. Email Address About Hillstream BiopharmaHillstream Biopharma (NASDAQ:CNTN), Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for cancer. The company’s research is centered on ferroptosis, a form of regulated cell death that can be used to target tumor cells, including cancers that may be resistant to conventional treatments. Hillstream’s proprietary technology platform is designed to develop ferroptosis-activating compounds. Its lead investigational program, HSB-1216, has been developed as a potential treatment for advanced solid tumors. The company has also identified additional preclinical candidates and continues to evaluate applications of its platform across oncology indications. Hillstream Biopharma is headquartered in New Jersey and is focused primarily on advancing its drug-development pipeline through preclinical and clinical research. The company’s securities have been associated with the Nasdaq symbol HILS; CNTN may not correspond to Hillstream Biopharma’s current ticker symbol.View Hillstream Biopharma ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles J.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingThese 3 Stocks Sit at the Center of NVIDIA’s Cybersecurity PushGold Has Gone Sideways, But These 3 Stocks Haven’tLennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing SlumpAeluma’s Selloff Could Be Setting Up Its Next Big MoveBraze Beat Expectations—Now 2 SaaS Peers Are in Focus Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
